Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients

ABSTRACT: Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients

PROVIDER: PRJNA513049 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [miRNA]

Project description:Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [miRNA]

| PRJNA513053 | ENA

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [mRNA]

Project description:Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [mRNA]

| PRJNA510425 | ENA

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [mRNA]

Project description:Expression microarray analyses was used to analyze 35 laryngeal squamous cell carcinoma (LSCC) with reference sample (pool of 5 normal tissue ). A quality control filter was applied based on Feature Extraction flags (empty spaces replacing values)

2019-07-31 | GSE123986 | GEO

Androgen receptor condensates as drug targets

Project description:Androgen receptor condensates as drug targets

| PRJNA974060 | ENA

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-07-31 | GSE124679 | GEO

Integrated miRNA and mRNA expression analysis uncovers drug targets in squamous cell carcinoma patients [miRNA]

Project description:Expression microarray analyses was used to analyze 35 LSCC with reference sample of 5 normal tissue. A quality control filter was applied based on Feature Extraction flags (empty spaces replacing values)

2019-07-31 | GSE124678 | GEO

Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets

Project description:We used mass-spectrometry based phosphoproteomics and computational methods to identify patient-specific drug targets in primary CCA and CCA-derived cell lines. We analyzed 13 primary CCA with matched background tissue and 8 different cell lines leading to the identification and quantification of >13,000 phosphorylation sites. Application of the Drug Ranking Using Machine Learning (DRUML) algorithm identified inhibitors of HDAC and PI3K pathway members as highly ranking in primary CCA relative to background. The accuracy of drug rankings based on predicted responses was confirmed using cell line models of CCA. Together, our study uncovers frequently overactive biochemical pathways in primary CCA and provides a proof-of-concept of the use of machine learning for ranking drugs based on efficacy within individual patient tumors.

2023-03-11 | PXD027329 | Pride

Molecular Mechanisms and Targets of the Cholehepatic Drug, NorUrsodeoxycholic Acid

Project description:Molecular Mechanisms and Targets of the Cholehepatic Drug, NorUrsodeoxycholic Acid

| PRJNA605731 | ENA

Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation

Project description:Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation

| PRJNA578095 | ENA

Integrated single-cell multiomics uncovers foundational regulatory mechanisms of lens development and pathology.

Project description:Integrated single-cell multiomics uncovers foundational regulatory mechanisms of lens development and pathology.

| PRJNA993020 | ENA